Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.34 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | PPARA | Q07869 | 2/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Di(Hydroxyethyl)Ether SCHEMBL2528560 | 0.91 | TSHR (0.48) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| Triethylene Glycol SCHEMBL11010343 | 0.88 | MEN1 (0.50) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| Pivalate SCHEMBL4885836 | 0.85 | TSHR (0.53) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| Pivalate SCHEMBL11109449 | 0.85 | TSHR (0.53) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| Triethylene Glycol SCHEMBL1640973 | 0.83 | MEN1 (0.55) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| Tetraethylene Glycol SCHEMBL4886960 | 0.83 | MEN1 (0.55) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| Ethylene Glycol SCHEMBL1171759 | 0.82 | TSHR (0.42) | TSHRALDH1A1MAPTCYP2D6CYP2C19 | |
| Ethylene Glycol SCHEMBL1271417 | 0.82 | TSHR (0.42) | TSHRALDH1A1MAPTCYP2D6CYP2C19 | |
| Di(Hydroxyethyl)Ether SCHEMBL11471879 | 0.79 | TSHR (0.46) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL15012611 | 0.77 | MEN1 (0.48) | TSHRMAPK1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12492293-B2 | Multi-component systems for preparing foamed products | ARKEMA FRANCE (FR) | 2025-12-09 | — | — | US | disclosed |
| US-12378450-B2 | Adhesive for endoscope and cured product thereof, and endoscope and method for producing the same | FUJIFILM CORPORATION (JP) | 2025-08-05 | — | — | US | disclosed |
| US-20250064687-A1 | DENTAL CURABLE COMPOSITION AND DENTAL PROSTHESIS COMPRISING BASE MATERIAL AND RESIN LAYER | KURARAY NORITAKE DENTAL INC. (JP) | 2025-02-27 | — | — | US | disclosed |
| EP-4458344-A1 | DENTAL CURABLE COMPOSITION AND DENTAL PROSTHESIS COMPRISING BASE MATERIAL AND RESIN LAYER | Kuraray Noritake Dental Inc. (JP) | 2024-11-06 | — | — | EP | disclosed |
| US-20240299258-A1 | DENTAL CURABLE COMPOSITION | KURARAY NORITAKE DENTAL INC. (JP) | 2024-09-12 | — | — | US | disclosed |
| WO-2024142769-A1 | RESIN COMPOSITION, COMPOSITE MATERIAL, AND CURED PRODUCTS OF THESE | 株式会社レゾナック | 2024-07-04 | — | — | WO | disclosed |
| EP-4364718-A1 | DENTAL CURABLE COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2024-05-08 | — | — | EP | disclosed |
| US-20240110071-A1 | Ultraviolet-Curable Water-Based Ink, Dispersion, Ultraviolet-Curable Water-Based Composition, and Printed Matter | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-04-04 | — | — | US | disclosed |
| EP-4328246-A1 | ULTRAVIOLET-CURABLE AQUEOUS INK, DISPERSION, ULTRAVIOLET-CURABLE AQUEOUS COMPOSITION, AND PRINTED MATTER | Mitsubishi Chemical Corporation (JP) | 2024-02-28 | — | — | EP | disclosed |
| EP-3891210-B1 | MULTI-COMPONENT SYSTEMS FOR PREPARING FOAMED PRODUCTS | ARKEMA FRANCE (FR) | 2023-08-23 | — | — | EP | disclosed |
| EP-2055726-A1 | THIOURETHANE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | Showa Denko K.K. (JP) | 2009-05-06 | — | — | EP | disclosed |
| US-20090023831-A1 | Curable Composition Containing Thiol Compound | SHOWA DENKO K.K. (JP) | 2009-01-22 | — | — | US | disclosed |
| EP-1983017-A1 | CURABLE COMPOSITION CONTAINING THIOL COMPOUND | Showa Denko K.K. (JP) | 2008-10-22 | — | — | EP | disclosed |
| EP-1629046-B1 | CURABLE POLYMER COMPOUND | SHOWA DENKO KK (JP) | 2008-05-14 | — | — | EP | disclosed |
| US-7341828-B2 | Thiol compound, photopolymerization initiator composition and photosensitive composition | SHOWA DENKO K.K. (JP) | 2008-03-11 | — | — | US | disclosed |
| US-20070021571-A1 | Curable polymer compound | SHOWA DENKO K.K. (JP) | 2007-01-25 | — | — | US | disclosed |
| US-20060079593-A1 | Hexaarylbiimidazole compounds and photopolymerization initiator compositions containing the same | SHOWA DENKO K.K. (JP) | 2006-04-13 | — | — | US | disclosed |
| US-20060041053-A1 | Color filter black matrix resist composition and carbon black dispersion composition used for the composition | SHOWA DENKO K.K. (JP) | 2006-02-23 | — | — | US | disclosed |
| US-20060036023-A1 | Color filter black matrix resist composition | SHOWA DENKO K.K. (JP) | 2006-02-16 | — | — | US | disclosed |
| US-20050153231-A1 | Thiol compound, photopolymerization initiator composition and photosensitive composition | SHOWA DENKO K.K. (JP) | 2005-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250064687-A1 | DENTAL CURABLE COMPOSITION AND DENTAL PROSTHESIS COMPRISING BASE MATERIAL AND RESIN LAYER | MGMT, SEM1, CARM1 | TSHR 3622/4885MAPK1 3230/4885MEN1 3326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.